Clinical Trial: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Severe Hypertriglyceridemia
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia (SHTG): The ENTRUST Study
Brief Summary:
To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ?500 to ?2000 mg/dL) after 26 weeks of treatment.
Read more